Who are RxSight, Inc.'s main suppliers?

RxSight, Inc. (RXST) key suppliers include: SINGLE-AND-SOLE-SOURCE-SUPPLIERS, CERTIFIED-SPECIALTY-CONTRACT-MANUFACTURERS, THIRD-PARTY-STERILIZATION-VENDOR, Johnson & Johnson, Johnson & Johnson. View the full supplier network at chainsifter.com/chain/RXST.

Who are RxSight, Inc.'s major customers?

RxSight, Inc. (RXST) key customers include: AMBULATORY-SURGERY-CENTERS, Johnson & Johnson, Johnson & Johnson, BOFA-SECURITIES-INC. View the full customer network at chainsifter.com/chain/RXST.

What sector is RxSight, Inc. in?

RxSight, Inc. (RXST) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

RXST Supply Chain: RxSight, Inc. Supplier List & 12 Relationships

5Suppliers

4Customers

3Debt Items

20Related Chains

RxSight, Inc. Suppliers

Ticker	Name	Confidence	Evidence
SINGLE-AND-SOLE-SOURCE-SUPPLIERS	SINGLE-AND-SOLE-SOURCE-SUPPLIERS	92%	We rely on third parties, including single and sole source suppliers, to manufacture certain components and subcomponents of our products and to provide raw materials, primarily chemicals for our LAL.
CERTIFIED-SPECIALTY-CONTRACT-MANUFACTURERS	CERTIFIED-SPECIALTY-CONTRACT-MANUFACTURERS	90%	We outsource the cables and circuit boards used in the LDD to certified specialty contract manufacturers.
THIRD-PARTY-STERILIZATION-VENDOR	THIRD-PARTY-STERILIZATION-VENDOR	85%	We also employ a third-party sterilization vendor.
JNJ	Johnson & Johnson	72%	f our RxSight system is beneficial in a broad range of patients, adoption of our product will be limited and may not occur as rapidly as we anticipate or at all, which would have a material adverse e…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from RXST graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from RXST graph: Reciprocal relationship from JNJ grap…

RxSight, Inc. Customers

Ticker	Name	Confidence	Evidence
AMBULATORY-SURGERY-CENTERS	AMBULATORY-SURGERY-CENTERS	90%	The Company maintains an allowance for credit losses resulting from the inability of its customers, including ambulatory surgery centers, to make required payments.
JNJ	Johnson & Johnson	72%	f our RxSight system is beneficial in a broad range of patients, adoption of our product will be limited and may not occur as rapidly as we anticipate or at all, which would have a material adverse e…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from RXST graph: f our RxSight system is beneficial in a broad range of patients, adoption of our product will be limited and may not o…
BOFA-SECURITIES-INC	BOFA-SECURITIES-INC	62%	mprehensive loss. Unrealized losses on available-for-sale debt securities as of December 31, 2024 and December 31, 2023 were not significant and were primarily due to changes in interest rates, inclu…

RxSight, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
RXST-DEBT-12327	Warrants outstanding: 100261	90%	xbrl warrant detail from xbrl 2022-12-31.
RXST-DEBT	Debt stack $10.8M	90%	Market cache reports total debt of $10.8M.
RXST-DEBT-12328	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2021-09-30.

RxSight, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for RxSight, Inc..

RxSight, Inc. Ownership

Holder	Name	Confidence	Evidence
RXST-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 164 tracked holders.

RxSight, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
ADGM	Adagio Medical Holdings, Inc.	100.00	2
ATON	AlphaTON Capital Corp	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
TRIB	Trinity Biotech plc	100.00	2
ABBV	AbbVie Inc.	100.00	2
AURA	Aura Biosciences, Inc.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
ACIU	AC Immune SA	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
AORT	Artivion, Inc.	100.00	2
ALC	Alcon Inc.	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2
FDMT	4D Molecular Therapeutics, Inc.	100.00	2

RxSight, Inc. Supply Chain